Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Raisman

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
European Journal of Pharmacology|February 10, 1984
Substituted tetrahydro-beta-carbolines are possible candidates as endogenous ligand of the [3H]imipramine recognition siteS Z Langer, R Raisman, L Tahraoui, et al.
The European Journal of Neuroscience|December 1, 1996
DA uptake sites, D1 and D2 receptors, D2 and preproenkephalin mRNAs and Fos immunoreactivity in rat striatal subregions after partial dopaminergic degenerationM Chritin, V Blanchard, R Raisman-Vozari, et al.
Neuroreport|March 3, 1997
An immunocytochemical study of a G-protein-gated inward rectifier K+ channel (GIRK2) in the weaver mouse mesencephalonC Adelbrecht, M G Murer, I Lauritzen, et al.
Neuroreport|April 20, 1999
Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigraK Parain, M G Murer, Q Yan, et al.
Journal of Neurochemistry|October 1, 1991
Quantitative autoradiography of tyrosine hydroxylase immunoreactivity in the rat brainR Raisman-Vozari, E Hirsch, F Javoy-Agid, et al.
Psychopharmacology|January 1, 1983
3H-Rauwolscine binding in platelets from depressed patients and healthy volunteersC Pimoule, M S Briley, C Gay, et al.
Brain Research|January 15, 1990
Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in manR Raisman-Vozari, J A Girault, S Moussaoui, et al.
The European Journal of Neuroscience|April 1, 1996
Reserpine affects differentially the density of the vesicular monoamine transporter and dihydrotetrabenazine binding sitesL Naudon, R Raisman-Vozari, R H Edwards, et al.
Brain Research. Molecular Brain Research|March 1, 1994
Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalonV Blanchard, R Raisman-Vozari, S Vyas, et al.
Journal of the Neurological Sciences|September 1, 1988
D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsyL Pierot, C Desnos, J Blin, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
European Journal of Pharmacology|February 10, 1984
Substituted tetrahydro-beta-carbolines are possible candidates as endogenous ligand of the [3H]imipramine recognition siteS Z Langer, R Raisman, L Tahraoui, et al.
The European Journal of Neuroscience|December 1, 1996
DA uptake sites, D1 and D2 receptors, D2 and preproenkephalin mRNAs and Fos immunoreactivity in rat striatal subregions after partial dopaminergic degenerationM Chritin, V Blanchard, R Raisman-Vozari, et al.
Neuroreport|March 3, 1997
An immunocytochemical study of a G-protein-gated inward rectifier K+ channel (GIRK2) in the weaver mouse mesencephalonC Adelbrecht, M G Murer, I Lauritzen, et al.
Neuroreport|April 20, 1999
Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigraK Parain, M G Murer, Q Yan, et al.
Journal of Neurochemistry|October 1, 1991
Quantitative autoradiography of tyrosine hydroxylase immunoreactivity in the rat brainR Raisman-Vozari, E Hirsch, F Javoy-Agid, et al.
Psychopharmacology|January 1, 1983
3H-Rauwolscine binding in platelets from depressed patients and healthy volunteersC Pimoule, M S Briley, C Gay, et al.
Brain Research|January 15, 1990
Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in manR Raisman-Vozari, J A Girault, S Moussaoui, et al.
The European Journal of Neuroscience|April 1, 1996
Reserpine affects differentially the density of the vesicular monoamine transporter and dihydrotetrabenazine binding sitesL Naudon, R Raisman-Vozari, R H Edwards, et al.
Brain Research. Molecular Brain Research|March 1, 1994
Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalonV Blanchard, R Raisman-Vozari, S Vyas, et al.
Journal of the Neurological Sciences|September 1, 1988
D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsyL Pierot, C Desnos, J Blin, et al.
Pageof 11